Business Context and Reporting Period
This Form 8-K was furnished by Vickers Vantage Corp. I, a Cayman Islands special purpose acquisition company, in connection with information posted by Scilex Holding Company on December 13, 2021. Scilex is described as a majority-owned subsidiary of Sorrento Therapeutics, Inc.
The filing reports that Scilex and Vickers Vantage Corp. I executed a letter of intent for a proposed business combination. The filing date is stated as December 13, 2021, although the signature page is dated February 18, 2022.
Financial and Operating Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, valuation, or other financial metrics. The referenced investor presentation is identified as Exhibit 99.1, but its substantive contents are not included in the provided filing text.
Material Changes Versus Prior Period
No period-to-period financial comparison or material operating change is disclosed. The principal reported development is the execution of a letter of intent relating to a proposed business combination between Scilex and Vickers Vantage Corp. I.
Guidance, Outlook, Risks, and Unusual Items
- The proposed transaction remains described as a business combination under a letter of intent; definitive transaction terms, closing conditions, timing, and completion status are not provided in the filing text.
- The filing furnishes, rather than files, the Item 7.01 information and Exhibit 99.1 for purposes of Section 18 of the Exchange Act, and states that the information is not incorporated by reference except where expressly specified.
- No management guidance, financial outlook, risk factors, contingencies, or unusual accounting items are disclosed in the provided text.
Key Facts for Investor Verification
- Review Exhibit 99.1 to assess Scilex’s business, transaction rationale, projected financial information, and any stated risks or conditions.
- Verify whether the letter of intent progressed to a definitive agreement and whether the proposed business combination closed.
- Confirm the transaction structure, ownership percentages, consideration, financing requirements, and shareholder or regulatory approvals.
- Reconcile the December 13, 2021 report date with the February 18, 2022 signature date.